Royalty Pharma PLC

RPRXNASDAQ · US

Holders

REDUCEDT+7
Hite Christopher
Royalty Pharma PLC · NASDAQ
−16,800 sh
Filed 19 Aug 2026SEC Form 4view source
REDUCEDT+7
Hite Christopher
Royalty Pharma PLC · NASDAQ
−100,000 sh · $6.0M
Filed 19 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Renaissance Technologies
Royalty Pharma PLC · NASDAQ
1,935,800 sh · $108.5M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Two Sigma Investments
Royalty Pharma PLC · NASDAQ
2,920,163 sh · $163.7M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Two Sigma Investments
Royalty Pharma PLC · NASDAQ
2,251,525 sh · $108.0M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDQuarterly
Renaissance Technologies
Royalty Pharma PLC · NASDAQ
790,937 sh · $37.9M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Viking Global Investors
Royalty Pharma PLC · NASDAQ
2,597,460 sh · $93.6M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Royalty Pharma PLC · NASDAQ
23,017,561 sh · $607.0M
Filed 30 Jun 2024SEC 13Fview source